Sort By:
Date
Title
Category:

Changing the culture of drug safety

In this commentary, that was published in MedNous May 2012, NDA’s Brian Edwards explains what companies need to know about new EU legislation.

| Pharmacovigilance

Impact of the Paediatric Regulation on existing medicinal products – a review

This article, written by NDAs Jill Challis and published in the Regulatory Rapporteur in October 2011, reviews the impact of the Regulation over the last five years on improving the likelihood for safer and more effective use of existing medicines in children. Children are not simply young adults when it comes to medicines. Factors affecting …

| Paediatrics, Regulatory Affairs

NDA Intelligence

Subscribe to the latest intelligence from the true thought leaders in the field and access it at any time.

Sign In

Create Account

By signing up you are agreeing to our terms of service